News Island Pharmaceuticals Limited

Equities

ILA

AU0000138869

Market Closed - Australian S.E. Other stock markets 23:14:20 2024-06-06 EDT			5-day change	1st Jan Change
0.062 ^AUD	+1.64%		-7.46%	-34.74%

05-08	Island Pharmaceuticals Reallocates Grant Funding to Dengue Fever Trial; Shares Rally 13%	MT
04-16	Island Pharmaceuticals Reports Positive Data from Dose Study of Dengue Medication	MT

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Island Pharmaceuticals Reallocates Grant Funding to Dengue Fever Trial; Shares Rally 13%	05-07	MT
Island Pharmaceuticals Reports Positive Data from Dose Study of Dengue Medication	04-16	MT
Island Pharmaceuticals to raise $1.95 million for ISLA-101 development	02-27	AQ
Island Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended December 31, 2023	02-25	CI
Australia Shares Fall as Central Bank Keeps Rates Steady	02-06	MT
Island Pharmaceuticals Achieves Primary Endpoint in Dengue Drug Ascending Dose Study	02-05	MT
Island Pharmaceuticals Doses Subjects with Third Cohort for Dengue Medication Study	01-18	MT
Island Pharmaceuticals' ISLA-101 Study Advances to Third Cohort Dosing	12-25	MT
Island Pharmaceuticals Signs R&D Loan Deal With Radium Capital	12-15	MT
Island Pharmaceuticals Announces Change of Company Secretaries	11-30	CI
Island Pharmaceuticals Administers First Drug Cohort for Dengue Medication Study	11-24	MT
Island Pharma one step closer to ISLA-101 dosing	11-22	AQ
Island Pharmaceuticals Begins Screening for Dengue Medication Study	11-13	MT
Island Pharmaceuticals Gets Nearly AU$390,000 R&D Tax Rebate; Shares Fall 4%	11-09	MT
Island Pharma welcomes green light for ISLA-101 clinical study	11-07	AQ
Island Pharmaceuticals Receives Ethics Approval for Ascending Dose Study	11-06	MT
Island Pharmaceuticals Secures Australian Patent for Flavivirus Treatment	11-02	MT
Island Pharma gearing up to start ISLA-101 trial for dengue fever	23-09-27	AQ
Island Pharmaceuticals to Start Dengue Drug Trial in October	23-09-26	MT
Island Pharmaceuticals Secures US Patent to Support Dengue Medication	23-09-13	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Island Pharmaceuticals Limited

Equities

ILA

AU0000138869

Summary

Filters